COSCIENS Biopharma Inc T.AEZ

Primary Symbol: T.AEZS

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:AEZS - Post by User

COSCIENS Biopharma Inc

Bullboard Posts

Comment by aett258on Dec 09, 2016 2:39pm

76 Views

Post# 25577830

RE:RE:RE:RE:Please help me understand this issue

Added to my position today. To me the reward outweighs the risk. From now to mid January I figure AEZ will increase quite a bit due to speculation at which time I will sell half my position and keep the rest for a possible phase 3 result.

Bullboard Posts

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!